Clean Science & Technology Limited has announced the convening of its 23rd Annual General Meeting (AGM) on Saturday, September 12, 2026, at 12:00 Noon (IST), to be held exclusively through Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The meeting will be conducted in compliance with the applicable provisions of the Companies Act, 2013, the Ministry of Corporate Affairs (MCA) General Circular No. 03/2025 dated September 22, 2025, and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company published newspaper advertisements in the Financial Express (English edition) and Loksatta (Marathi edition) on August 12, 2026, pursuant to Regulation 30 and Regulation 47 of the SEBI Listing Regulations.

AGM Key Details

The following table summarises the key parameters of the 23rd AGM:

Dividend Recommendation for FY2025-26

The Board of Directors, at its meeting held on May 14, 2026, recommended a final dividend of ₹4.00 per equity share of face value ₹1/- each for the financial year 2025-26. This recommendation is subject to approval by shareholders at the 23rd AGM. The record date for determining dividend eligibility has been fixed as Saturday, September 5, 2026.

Upon approval at the AGM, the final dividend will be paid electronically to members whose bank account details are registered with their Depository Participant or the company's Registrar and Share Transfer Agent, KFin Technologies Limited (formerly known as Link Intime India Private Limited). Members for whom electronic payment is not feasible will receive dividend warrants, demand drafts, or cheques by post.

Tax Deduction at Source (TDS) on Dividend

In accordance with the provisions of the Finance Act, 2020, dividend income is taxable in the hands of shareholders, and the company is required to deduct tax at source (TDS) at applicable rates under the Income Tax Act, 1961. Members seeking tax exemption or deduction at a lower rate are required to submit the necessary documents by Saturday, September 5, 2026.

Members who have not registered or updated their email addresses and/or bank account details are advised to do so as follows:

AGM Notice Distribution and E-Voting Facility

The AGM notice and the Annual Report for FY2025-26 will be distributed electronically to members whose email addresses are registered with their Depository Participant or the company's Registrar and Share Transfer Agent. These documents will also be available on:

• The company's website: https://cleanscience.co.in/investors/annual-report/
• NSDL's website: https://www.evoting.nsdl.com/
• BSE Limited: https://www.bseindia.com/
• National Stock Exchange of India Limited: https://www.nseindia.com/

The company is providing a remote e-voting facility for all agenda items listed in the AGM notice. Members attending the AGM via VC/OAVM who have not exercised their vote through remote e-voting will also be permitted to vote electronically during the AGM. Members without registered email addresses are advised to follow the registration procedure outlined in the AGM notice to obtain their User ID and password for participation in the remote e-voting process.

The AGM filing was submitted to the stock exchanges on August 12, 2026, and was signed by Ruchita Vij, Company Secretary and Compliance Officer of Clean Science and Technology Limited.

Clean Science & Technology reported its highest-ever consolidated sales of approximately ₹264 crore in the first quarter of fiscal year 2027 (Q1 FY27), driven by a strategic collaboration with Swiss partner Geneus Chem and a long-term supply agreement with Kemin. Despite geopolitical headwinds impacting raw material supply and shipping availability, the company achieved sequential revenue growth of 7% and year-on-year revenue growth of 10%. The earnings call transcript, released on August 6, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, highlights significant progress in diversifying its product portfolio through advanced HALS chemistry.

The company’s standalone revenue improved by 5% sequentially to ₹203 crore, primarily due to better realizations across all products. Consolidated EBITDA stood at ₹96 crore with a margin of 37%, while net profit (PAT) was ₹73 crore, reflecting a margin of 28%. Managing Director Siddharth Sikchi noted that while volumes were moderated by supply-side challenges, including a two-week production shutdown due to raw material unavailability in India, demand remained steady. The company successfully mitigated these disruptions by securing safety stocks and optimizing supply chain logistics.

Strategic Partnerships and Product Diversification

A key development during the quarter was the entry into a strategic collaboration with Geneus Chem, a Swiss entity specializing in advanced HALS technologies. This partnership involves technology transfer for patented NOR HALS products, which are higher-grade stabilizers used in harsh agricultural film environments. Clean Science will manufacture these products at its Clean Fino-Chem facility, with commercialization expected by Q3 FY27. The company projects additional revenue of ₹300–350 crore over the next three to four years from this collaboration alone. The arrangement includes co-branding and defined geographical marketing rights to avoid conflict.

Additionally, Clean Science signed a definitive five-year supply contract with Kemin, a global leader in food and feed ingredients. This agreement secures offtake for BHA, BHT, TBHQ, and AP products, increasing Kemin’s procurement from the company by 20% to 40%. Siddharth Sikchi emphasized that this deal provides supply security for both parties and leverages their decade-long relationship. The company is initiating capacity expansion to meet this increased demand.

Operational Updates and Financial Metrics

The HALS segment continues to be a major growth driver, now constituting 22% of total sales. Exports accounted for nearly 50% of HALS sales in Q1 FY27, up from purely domestic sales in the previous year. Volumes for HALS were approximately 1,000 tons, with an improved mix towards higher grades, reducing the reliance on legacy products like HALS 770 from 50% to 35%. The company’s subsidiary, Clean Fino-Chem Limited (CFCL), reached operational self-sustainability, having fully recovered its operating expenses. Total investment in CFCL now stands at approximately ₹850 crore, following a capital infusion of ₹100 crore in the quarter.

Note: Comparative figures derived from management commentary on growth rates.

What the Numbers Show

The divergence between standalone and consolidated performance highlights the impact of the HALS scale-up. While standalone revenue grew modestly due to pricing improvements offsetting volume declines from supply chain issues, consolidated results benefited significantly from the higher-margin HALS business. The reduction in reliance on top four legacy products—from 85% in Q4 FY23 to 60% in Q1 FY27—demonstrates successful portfolio diversification. Furthermore, the stabilization of the hydroquinone and catechol plant positions the company to add incremental revenue streams in the coming quarters, although Performance Chemical 2 is expected to commence commercial operations only in Q3 FY27.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE227W01023/acef25fa-9887-432d-8c62-66641878869e.pdf